» Articles » PMID: 22547472

Serum 25-hydroxyvitamin D Concentration and Risk for Major Clinical Disease Events in a Community-based Population of Older Adults: a Cohort Study

Overview
Journal Ann Intern Med
Specialty General Medicine
Date 2012 May 2
PMID 22547472
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Circulating concentrations of 25-hydroxyvitamin D [25-(OH)D] are used to define vitamin D deficiency. Current clinical 25-(OH)D targets based on associations with intermediate markers of bone metabolism may not reflect optimal levels for other chronic diseases and do not account for known seasonal variation in 25-(OH)D concentration.

Objective: To evaluate the relationship of 25-(OH)D concentration with the incidence of major clinical disease events that are pathophysiologically relevant to vitamin D.

Design: Cohort study.

Setting: The Cardiovascular Health Study conducted in 4 U.S. communities. Data from 1992 to 2006 were included in this analysis.

Participants: 1621 white older adults.

Measurements: Serum 25-(OH)D concentration (using a high-performance liquid chromatography-tandem mass spectrometry assay that conforms to National Institute of Standards and Technology reference standards) and associations with time to a composite outcome of incident hip fracture, myocardial infarction, cancer, or death.

Results: Over a median 11-year follow-up, the composite outcome occurred in 1018 participants (63%). Defining events included 137 hip fractures, 186 myocardial infarctions, 335 incidences of cancer, and 360 deaths. The association of low 25-(OH)D concentration with risk for the composite outcome varied by season (P = 0.057). A concentration lower than a season-specific Z score of -0.54 best discriminated risk for the composite outcome and was associated with a 24% higher risk in adjusted analyses (95% CI, 9% to 42%). Corresponding season-specific 25-(OH)D concentrations were 43, 50, 61, and 55 nmol/L (17, 20, 24, and 22 ng/mL) in winter, spring, summer, and autumn, respectively.

Limitation: The observational study was restricted to white participants.

Conclusion: Threshold concentrations of 25-(OH)D associated with increased risk for relevant clinical disease events center near 50 nmol/L (20 ng/mL). Season-specific targets for 25-(OH)D concentration may be more appropriate than static targets when evaluating health risk.

Primary Funding Source: National Institutes of Health.

Citing Articles

Glucose regulation and association with Vitamin D and parathyroid hormone - differences across Middle Eastern and Caucasian ethnicities.

Dhaher N, Wandell P, Bennet L J Diabetes Metab Disord. 2024; 24(1):15.

PMID: 39712337 PMC: 11659546. DOI: 10.1007/s40200-024-01543-y.


Association of 25-hydroxyvitamin D with risk of overall and colorectal cancer among Japanese using a Mendelian randomization approach.

Katagiri R, Goto A, Nakano S, Nakatochi M, Koyanagi Y, Iwagami M Sci Rep. 2023; 13(1):2384.

PMID: 36765195 PMC: 9918529. DOI: 10.1038/s41598-023-29596-8.


Relationship between serum vitamin D and hip fracture in the elderly: a systematic review and meta-analysis.

Ghahfarrokhi S, Mohammadian-Hafshejani A, Sherwin C, Heidari-Soureshjani S J Bone Miner Metab. 2022; 40(4):541-553.

PMID: 35639176 DOI: 10.1007/s00774-022-01333-7.


Associations Between 25-Hydroxyvitamin D, Kidney Function, and Insulin Resistance Among Adults in the United States of America.

Geng J, Qiu Y, Li Y, Li J, Liao R, Du H Front Nutr. 2022; 8:716878.

PMID: 35242790 PMC: 8885514. DOI: 10.3389/fnut.2021.716878.


Non-Musculoskeletal Benefits of Vitamin D beyond the Musculoskeletal System.

Zhang S, Miller D, Li W Int J Mol Sci. 2021; 22(4).

PMID: 33669918 PMC: 7924658. DOI: 10.3390/ijms22042128.


References
1.
Giovannucci E, Liu Y, Hollis B, Rimm E . 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med. 2008; 168(11):1174-80. PMC: 3719391. DOI: 10.1001/archinte.168.11.1174. View

2.
Looker A, Pfeiffer C, Lacher D, Schleicher R, Picciano M, Yetley E . Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. Am J Clin Nutr. 2008; 88(6):1519-27. PMC: 2745830. DOI: 10.3945/ajcn.2008.26182. View

3.
Fried L, Borhani N, Enright P, Furberg C, Gardin J, Kronmal R . The Cardiovascular Health Study: design and rationale. Ann Epidemiol. 1991; 1(3):263-76. DOI: 10.1016/1047-2797(91)90005-w. View

4.
Cauley J, LaCroix A, Wu L, Horwitz M, Danielson M, Bauer D . Serum 25-hydroxyvitamin D concentrations and risk for hip fractures. Ann Intern Med. 2008; 149(4):242-50. PMC: 2743412. DOI: 10.7326/0003-4819-149-4-200808190-00005. View

5.
Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B . Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med. 2008; 168(12):1340-9. DOI: 10.1001/archinte.168.12.1340. View